Patents by Inventor Ofer Levy

Ofer Levy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190246633
    Abstract: The present invention discloses a process for the preparation of an aqueous pesticide dispersion comprising the steps of: a) dissolving a pesticidal active ingredient in a water miscible organic solvent to obtain a pesticide solution; b) mixing the pesticide solution with water in the presence of surface active agents to form aqueous pesticide dispersion. This invention further discloses a method for controlling pests comprising of diluting the aqueous pesticide dispersion of the present invention in water to obtain diluted aqueous pesticide dispersions and applying an effective amount of said diluted dispersion to a site.
    Type: Application
    Filed: April 25, 2019
    Publication date: August 15, 2019
    Applicant: ADAMA MAKHTESHIM LTD.
    Inventors: Ganit Levy-Ruso, Ofer Toledano
  • Patent number: 10331452
    Abstract: In accordance with embodiments disclosed herein, there is provided systems and methods for tracking the mode of processing devices in an instruction tracing system. The method may include receiving an indication of a change in a current execution mode of the processing device. The method may also include determining that the current execution mode of the received indication is different than a value of an execution mode of a first execution mode (EM) packet previously-generated by the IT module. The method may also include generating, based on the determining that the current execution mode is different, a second EM packet that provides a value of the current execution mode of the processing device to indicate the change in the execution mode for an instruction in a trace generated by the IT module. The method may further include generating transactional memory (TMX) packets having n bit mode pattern in the packet log. The n is at least two and the n bit mode indicates transaction status of the TMX operation.
    Type: Grant
    Filed: June 27, 2013
    Date of Patent: June 25, 2019
    Assignee: Intel Corporation
    Inventors: Thilo Schmitt, Peter Lachner, Beeman Strong, Ofer Levy, Thomas Toll, Matthew Merten, Tong Li, Ravi Rajwar, Konrad Lai
  • Publication number: 20190167316
    Abstract: A facet distraction prosthesis includes an array of facet distraction base elements, connected to each other by a set of connector elements located at adjacent base elements. The set of connector elements includes a male connector having an at least partial cylindrical or spherical contour that is received in, and articulates with, an at least partial cylindrical or spherical recess of a female connector, so that adjacent ones of the base elements can bend in multiple degrees of freedom about different bending axes with respect to each other and adapt to a geometry of a facet joint.
    Type: Application
    Filed: December 6, 2017
    Publication date: June 6, 2019
    Applicant: Zygofix Ltd.
    Inventors: Uri Arnin, Ofer Levy
  • Publication number: 20190167445
    Abstract: A delivery device includes a guide tool and an impact tool. The guide tool includes an elongate body formed with a longitudinal guide channel, whose inner perimeter is made to complement an outer contour of an implant. The elongate body is formed with a longitudinal impact-tool channel, whose inner perimeter is made to complement an outer contour of the impact tool.
    Type: Application
    Filed: December 6, 2017
    Publication date: June 6, 2019
    Applicant: Zygofix Ltd.
    Inventors: Uri Arnin, Ofer Levy
  • Patent number: 10152451
    Abstract: Methods and apparatus are disclosed using an index array and finite state machine for scatter/gather operations. Embodiment of apparatus may comprise: decode logic to decode scatter/gather instructions and generate micro-operations. An index array holds a set of indices and a corresponding set of mask elements. A finite state machine facilitates the scatter operation. Address generation logic generates an address from an index of the set of indices for at least each of the corresponding mask elements having a first value. Storage is allocated in a buffer for each of the set of addresses being generated. Data elements corresponding to the set of addresses being generated are copied to the buffer. Addresses from the set are accessed to store data elements if a corresponding mask element has said first value and the mask element is changed to a second value responsive to completion of their respective stores.
    Type: Grant
    Filed: April 18, 2017
    Date of Patent: December 11, 2018
    Assignee: Intel Corporation
    Inventors: Zeev Sperber, Robert Valentine, Shlomo Raikin, Stanislav Shwartsman, Gal Ofir, Igor Yanover, Guy Patkin, Ofer Levy
  • Publication number: 20180352554
    Abstract: A device implementing a system for coexistence of collocated radios may include a first radio circuit configured to receive, from a collocated second radio circuit, a start indication for cellular activity associated with a radio resource control connection. The first radio circuit may be configured to, responsive to receiving the start indication, stop a wireless transmission capability. The first radio circuit may be configured to receive, from the collocated cellular circuit, an end indication for the cellular activity prior to the radio resource control connection being released. The first radio circuit may be configured to resume the wireless transmission capability in accordance with a reduced power level response to receiving the end indication.
    Type: Application
    Filed: November 29, 2017
    Publication date: December 6, 2018
    Inventors: Paul V. FLYNN, Vijay VENKATARAMAN, Artiom SHAMIS, Ofer LEVY, Veerendra BOODANNAVAR
  • Publication number: 20180305451
    Abstract: According to at least some embodiments of the present invention is directed to anti-HIDE1 antibodies and polypeptides and methods of using same.
    Type: Application
    Filed: July 13, 2016
    Publication date: October 25, 2018
    Inventors: Yosef DICKEN, Liat DASSA, Amit NOVIK, Amir TOPORIK, Gad COJOCARU, Yossef KLIGER, Yair BENITA, Ofer LEVY, Ilan VAKNIN, Arthur MACHLENKIN, Iris HECHT, Jungmin KIM, Andrew POW, Andrew W DRAKE
  • Publication number: 20180298109
    Abstract: This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against VSIG1, ILDR1, LOC253012, AI216611, C1ORF32 or FXYD3 antigens, which are predicted co-stimulatory family members and which are differentially expressed in cancers including, lung cancer, ovarian cancer, and colon cancer, and diagnostic and therapeutic usages. The use of these antibodies for modulating B7 costimulation and related therapies such as the treatment of autoimmunity are also provided. This invention further relates to the discovery of extracellular domains of VSIG1 and its variants, FXYD3 and its variants, ILDR1 and its variants, LOC253012 and its variants, AI216611 and its variants, and C1ORF32 and its variants which are suitable targets for immunotherapy, cancer therapy, and drug development.
    Type: Application
    Filed: January 29, 2018
    Publication date: October 18, 2018
    Inventors: Anat COHEN-DAYAG, Merav BEIMAN, Liat DASSA, Marina BUBIS, Shirley SAMEACH GREENWALD, Dalit LANDESMAN-MILO, Cynthia KOIFMAN, Ofer LEVY, Sergey NEMZER, Tania PERGAM, Yaron KINAR, Zurit LEVINE, Avi ROSENBERG, Galit ROTMAN, Eve MONTIA, Amit NOVIK, Amir TOPORIK, Shira WALACH
  • Patent number: 10098934
    Abstract: This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against VSIG1, ILDR1, LOC253012, AI216611, C1ORF32 or FXYD3 antigens, which are predicted co-stimulatory family members and which are differentially expressed in cancers including, lung cancer, ovarian cancer, and colon cancer, and diagnostic and therapeutic usages. The use of these antibodies for modulating B7 costimulation and related therapies such as the treatment of autoimmunity are also provided. This invention further relates to the discovery of extracellular domains of VSIG1 and its variants, FXYD3 and its variants, ILDR1 and its variants, LOC253012 and its variants, AI216611 and its variants, and C1ORF32 and its variants awhich are suitable targets for immunotherapy, cancer therapy, and drug development.
    Type: Grant
    Filed: March 18, 2013
    Date of Patent: October 16, 2018
    Assignee: COMPUGEN LTD
    Inventors: Zurit Levine, Amir Toporik, Amit Novik, Anat Cohen-Dayag, Avi Rosenberg, Cynthia Koifman, Dalit Landesman-Milo, Eve Montia, Galit Rotman, Liat Dassa, Marina Bubis, Merav Beiman, Ofer Levy, Sergey Nemzer, Shira Walach, Shirley Sameach- Greenwald, Tania Pergam, Yaron Kinar
  • Publication number: 20180217839
    Abstract: An example processor that includes a decoder, an execution circuit, a counter, and a last branch recorder (LBR) register. The decoder may decode a branch instruction for a program. The execution circuit may be coupled to the decoder, where the execution circuit may execute the branch instruction. The counter may be coupled to the execution circuit, where the counter may store a cycle count. The LBR register coupled to the execution circuit, where the LBR register may include a counter field to store a first value of the counter when the branch instruction is executed and a type field to store type information indicating a type of the branch instruction.
    Type: Application
    Filed: February 2, 2017
    Publication date: August 2, 2018
    Inventors: Michael W. Chynoweth, Jonathan D. Combs, Joseph K. Olivas, Beeman C. Strong, Rajshree A. Chabukswar, Ahmad Yasin, Jason W. Brandt, Ofer Levy, John M. Esper, Andreas Kleen, Christopher M. Chrulski
  • Patent number: 9971603
    Abstract: Some implementations provide techniques and arrangements for causing an interrupt in a processor in response to an occurrence of a number of events. A first event counter counts the occurrences of a type of event within the processor and outputs a signal to activate a second event counter in response to reaching a first predefined count. The second event counter counts the occurrences of the type of event within the processor and causes an interrupt of the processor in response to reaching a second predefined count.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: May 15, 2018
    Assignee: Intel Corporation
    Inventors: Ahmad Yasin, Peggy J. Irelan, Ofer Levy, Emile Ziedan, Grant G. Zhou
  • Publication number: 20180096140
    Abstract: In an embodiment, a processor for Return Oriented Programming (ROP) detection includes at least one execution unit; a plurality of event counters, each event counter associated with a unique type of a plurality of types of control transfer events; and a ROP detection unit. The ROP detection unit may be to: adjust a first event counter in response to detection of a first type of control transfer events; in response to a determination that the first event counter exceeds a first threshold, access a first configuration register associated with the first event counter to read configuration data; identify a set of ROP heuristic checks based on the configuration data read from the first configuration register; and perform each ROP heuristic check of the identified set of ROP heuristic checks. Other embodiments are described and claimed.
    Type: Application
    Filed: September 30, 2016
    Publication date: April 5, 2018
    Inventors: YURIY BULYGIN, GIDEON GERZON, SAMEER DESAI, HISHAM SHAFI, ANDREW A. FURTAK, OLEKSANDR BAZHANIUK, MIKHAIL V. GOROBETS, RAVI L. SAHITA, OFER LEVY
  • Patent number: 9884089
    Abstract: Described herein is a method of mitigating, in a subject (individual), tissue injury resulting from exposure to radiation (accidental/unintentional or intentional, such as therapeutic), chemoradiotherapy, disease, toxin, or drug or biologic mediated therapy.
    Type: Grant
    Filed: June 1, 2016
    Date of Patent: February 6, 2018
    Assignees: Dana-Farber Cancer Institute, Inc., Children's Medical Center Corporation
    Inventors: Eva Guinan, Ofer Levy
  • Publication number: 20180004532
    Abstract: A processor includes a front end including circuitry to decode an instruction from an instruction stream and a core including circuitry to process the instruction. The core includes an execution pipeline, a dynamic core frequency logic unit, and a counter compensation logic unit. The execution pipeline includes circuitry to execute the instruction. The dynamic core frequency logic unit includes circuitry to squash a clock of the core to reduce a core frequency. The clock may not be visible to software. The counter compensation logic unit includes circuitry to adjust a performance counter increment associated with a performance counter based on at least the dynamic core frequency logic unit circuitry to squash a clock of the core to reduce a core frequency.
    Type: Application
    Filed: July 1, 2016
    Publication date: January 4, 2018
    Inventors: Ahmad Yasin, Eti Pardo-Fridman, Ofer Levy
  • Patent number: 9858411
    Abstract: A method comprises filtering branch trap events at a branch event filter, monitoring a branch event filter to capture indirect branch trap events that cause a control flow trap exception, receiving the indirect branch trap events at a handler and the handler processing the indirect branch trap events.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: January 2, 2018
    Assignee: INTEL CORPORATION
    Inventors: Ravi Sahita, Xiaoning Li, Barry E. Huntley, Ofer Levy, Vedvyas Shanbhogue, Yuriy Bulygin, Ido Ouziel, Michael Lemay, John M. Esper
  • Publication number: 20170354712
    Abstract: Described herein is a method of mitigating, in a subject (individual), tissue injury resulting from exposure to radiation (accidental/unintentional or intentional, such as therapeutic), chemoradiotherapy, disease, toxin, or drug or biologic mediated therapy.
    Type: Application
    Filed: June 1, 2016
    Publication date: December 14, 2017
    Applicants: Dana-Farber Cancer Institute, Inc., Children's Medical Center Corporation
    Inventors: Eva Guinan, Ofer Levy
  • Publication number: 20170351641
    Abstract: Methods and apparatus are disclosed using an index array and finite state machine for scatter/gather operations. Embodiment of apparatus may comprise: decode logic to decode scatter/gather instructions and generate micro-operations. An index array holds a set of indices and a corresponding set of mask elements. A finite state machine facilitates the scatter operation. Address generation logic generates an address from an index of the set of indices for at least each of the corresponding mask elements having a first value. Storage is allocated in a buffer for each of the set of addresses being generated. Data elements corresponding to the set of addresses being generated are copied to the buffer. Addresses from the set are accessed to store data elements if a corresponding mask element has said first value and the mask element is changed to a second value responsive to completion of their respective stores.
    Type: Application
    Filed: April 18, 2017
    Publication date: December 7, 2017
    Inventors: ZEEV SPERBER, ROBERT VALENTINE, SHLOMO RAIKIN, STANISLAV SHWARTSMAN, GAL OFIR, IGOR YANOVER, GUY PATKIN, OFER LEVY
  • Patent number: 9770484
    Abstract: Described herein is a method of mitigating, in a subject (individual), tissue injury resulting from exposure to radiation (accidental/unintentional or intentional, such as therapeutic), chemoradiotherapy, disease, toxin, or drug or biologic mediated therapy.
    Type: Grant
    Filed: June 1, 2016
    Date of Patent: September 26, 2017
    Assignees: Dana-Farber Cancer Institute, Inc., Children's Medical Center Corporation
    Inventors: Eva Guinan, Ofer Levy
  • Patent number: 9770483
    Abstract: Described herein is a method of mitigating, in a subject (individual), tissue injury resulting from exposure to radiation (accidental/unintentional or intentional, such as therapeutic), chemoradiotherapy, disease, toxin, or drug or biologic mediated therapy.
    Type: Grant
    Filed: April 5, 2012
    Date of Patent: September 26, 2017
    Assignees: Dana-Farber Cancer Institute, Inc., Children's Medical Center Corporation
    Inventors: Eva Guinan, Ofer Levy
  • Publication number: 20170262290
    Abstract: Some implementations provide techniques and arrangements for causing an interrupt in a processor in response to an occurrence of a number of events. A first event counter counts the occurrences of a type of event within the processor and outputs a signal to activate a second event counter in response to reaching a first predefined count. The second event counter counts the occurrences of the type of event within the processor and causes an interrupt of the processor in response to reaching a second predefined count.
    Type: Application
    Filed: February 21, 2017
    Publication date: September 14, 2017
    Inventors: AHMAD YASIN, PEGGY J. IRELAN, OFER LEVY, EMILE ZIEDAN, GRANT G. ZHOU